Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia-Rou Liu

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cardiovascular Diabetology|August 10, 2014
Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studiesShang-Hung Chang, Lung-Sheng Wu, Meng-Jiun Chiou, et al.
Internal Medicine Journal|May 30, 2018
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort studyHsin-Fu Lee, Lai-Chu See, Yi-Hsin Chan, et al.
Digestive Diseases and Sciences|April 4, 2015
The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based StudyChia-Jung Kuo, Kuang-Hui Yu, Lai-Chu See, et al.
Cardiovascular Diabetology|October 1, 2020
Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitorHsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, et al.
Cardiovascular Diabetology|December 21, 2017
Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in TaiwanChia-Yu Chang, Yung-Hsin Yeh, Yi-Hsin Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2020
Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant HyperthyroidismYi-Hsin Chan, Lung-Sheng Wu, Lai-Chu See, et al.
Medicine|March 18, 2016
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort StudyWen-Kuan Huang, Hung-Chih Hsu, Jia-Rou Liu, et al.
Cardiovascular Diabetology|April 4, 2016
A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in TaiwanLung-Sheng Wu, Shang-Hung Chang, Gwo-Jyh Chang, et al.
Aging|April 10, 2023
Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort studyChieh-Li Yen, Chao-Yi Wu, Chung-Ying Tsai, et al.
The Canadian Journal of Cardiology|June 4, 2020
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort StudyHsin-Fu Lee, Yi-Hsin Chan, Pei-Ru Li, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cardiovascular Diabetology|August 10, 2014
Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studiesShang-Hung Chang, Lung-Sheng Wu, Meng-Jiun Chiou, et al.
Internal Medicine Journal|May 30, 2018
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort studyHsin-Fu Lee, Lai-Chu See, Yi-Hsin Chan, et al.
Digestive Diseases and Sciences|April 4, 2015
The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based StudyChia-Jung Kuo, Kuang-Hui Yu, Lai-Chu See, et al.
Cardiovascular Diabetology|October 1, 2020
Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitorHsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, et al.
Cardiovascular Diabetology|December 21, 2017
Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in TaiwanChia-Yu Chang, Yung-Hsin Yeh, Yi-Hsin Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2020
Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant HyperthyroidismYi-Hsin Chan, Lung-Sheng Wu, Lai-Chu See, et al.
Medicine|March 18, 2016
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort StudyWen-Kuan Huang, Hung-Chih Hsu, Jia-Rou Liu, et al.
Cardiovascular Diabetology|April 4, 2016
A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in TaiwanLung-Sheng Wu, Shang-Hung Chang, Gwo-Jyh Chang, et al.
Aging|April 10, 2023
Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort studyChieh-Li Yen, Chao-Yi Wu, Chung-Ying Tsai, et al.
The Canadian Journal of Cardiology|June 4, 2020
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort StudyHsin-Fu Lee, Yi-Hsin Chan, Pei-Ru Li, et al.
Pageof 4